Skip to content
Hemispherx Biopharma, Inc. Logo
  • COMPANY
  • PRODUCTS
  • R & D
    • Product Candidates Overview
    • Pipeline
    • Orphan Drug Designations
  • PARTNERING
  • INVESTOR RELATIONS
    • Press Releases
    • Events & Presentations
    • Stock Information
    • SEC Filings
    • XBRL Filings
    • Stockholder Meeting
    • Corporate Governance
    • Email Alerts
    • Investor Contact
  • BLOG
  • CONTACT

Press Releases

 
Dec 18, 2002
Rebroadcast of Hemispherx's December 18, 2002 Conference Call Available On Company's Website or Via Telephone Replay

Dec 17, 2002
Hemispherx Presents New Data from Phase IIB Clinical Trial of RNA-based Ampligen® for Structured Treatment Interruption in HIV at DART Conference

Dec 17, 2002
Hemispherx to Host Conference Call on Recent Presentation at the 2002 DART Conference and Other Recent Developments

Dec 16, 2002
Hemispherx Files New US Patent Application on Immune-Based Alternative Treatment to HIV/AIDS

Dec 09, 2002
HEMISPHERX BIOPHARMA COMPLETES FULL ENROLLMENT OF ITS PHASE III CLINICAL TRIAL FOR CHRONIC FATIGUE SYNDROME (CFS)

Nov 25, 2002
Hemispherx Biopharma Invited to Present New Anti HIV Data at DART Conference: Phase IIB Clinical Trials of Strategic Treatment Intervention

Nov 20, 2002
Hemispherx Biopharma, Inc. Adopts Stockholder Rights Plan

Nov 18, 2002
Hemispherx Biopharma and Sigma-Aldrich Enter Agreement to Produce Hemispherx's RNA-based Ampligen® in U.S.

Nov 15, 2002
Hemispherx Announces Third Quarter Results

Nov 04, 2002
Hemispherx Biopharma RNA Drug Technology Targets New Molecular Defects Uncovered in Prostate Cancer

 64   65   66   67   68     69    70   71   72   73 
 <<   <   >   >> 
Hemispherx Biopharma, Inc. Logo White

Latest News

  • CEO Roadshow Interviews Hemispherx Thomas K. Equels
  • Introducing You to the First Ampligen Quarterly Update
  • Proactive Investors USA Sits Down with Hemispherx CEO Thomas K. Equels

Privacy / Terms of Use

  • Terms Of Use
  • Investor Contact

Tweets by AIM Immuno

© Copyright | All Rights Reserved | AIM ImmunoTech Inc. | Privacy Policy | Terms of Use
FacebookTwitterYouTubeLinkedIn

Privacy
Resize Viewer - Reduce Resize Viewer - Expand Close window